Open AccessSurvival outcomes and predictors of mortality, re-bleeding and complications for acute severe variceal bleeding requiring balloon tamponade
Author(s) -
Charlotte Keung,
Aparna Morgan,
Suong Le,
Marcus Robertson,
Paul Urquhart,
Michael P. Swan
Publication year - 2022
Publication title -
world journal of hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.913
H-Index - 55
ISSN - 1948-5182
DOI - 10.4254/wjh.v14.i8.1584
Subject(s) - medicine , balloon tamponade , tamponade , retrospective cohort study , surgery , cohort , transjugular intrahepatic portosystemic shunt , univariate analysis , population , multivariate analysis , portal hypertension , cirrhosis , environmental health
Acute severe variceal bleeding (AVB) refractory to medical and endoscopic therapy is infrequent but associated with high mortality. Historical cohort studies from 1970-1980s no longer represent the current population as balloon tamponade is no longer first-line therapy for variceal bleeding; treatments including vasoactive therapies, intravenous antibiotics, endoscopic variceal band ligation are routinely used, and there is improved access to definitive treatments including transjugular intrahepatic portosystemic shunts. However, only a few studies from the current era exist to describe the practice of balloon tamponade, its outcomes, and predictors with a requirement for further updated information.